National University Hospital, NUH

NUHS Tower Block Level 8,
Department of Surgery

1E Kent Ridge Road,

Singapore 119228

Fax: (+65) 6777 8427


© 2018 - 2019 by NUH


Professor Marc POCARD


Department of Digestive & Oncologic Surgical,

Lariboisiere Hospital


International Society for the Study of Pleura & Peritoneum

Director ,

Research Unit CAP Paris-Tech,


Prof. Marc Pocard did his residency in the Paris Hospitals and during the same time studied colorectal cancer biology at the Curie Institut. He worked during 5 years as a surgeon at the Gustave Roussy Institut in Paris during which he also had the opportunity to work on peritoneal metastatic diseases.


In 2006 he was nominated Professor in digestive surgery at the Paris Diderot University. He developed a peritoneal metastasis treatment program, in association with the French RENAPE network for rare peritoneal cancers.

In 2009 he created a research Unit at the INSERM on Angiogenesis and again in 2019 a research Unit specifically devoted to basic and translational research on peritoneal metastasis. He practices HIPEC and PIPAC in  a routine manner and is involved in clinical trials related to peritoneal metastasis.

In 2018 he co-founded the ISSPP and was elected as the first president of the ISSPP society.

Professor Jimmy SO

Head & Senior Consultant, 
Division of Surgical Oncology, 
National University Cancer Institute, Singapore (NCIS), 
Director and Senior Consultant, 
Division of General Surgery (Upper Gastrointestinal Surgery), 
University Surgical Cluster, 
National University Hospital (NUH), Singapore

Prof. Jimmy So received his surgical training in National University Hospital, Singapore. He was trained in Upper Gastrointestinal Surgery, Surgical Oncology, Bariatric Surgery, Therapeutic Endoscopy and Minimally Invasive Surgery. He received fellowship training at Massachusetts General Hospital, Harvard Medical School, USA. He was also appointed as visiting consultant surgeon in Esophageal and Gastric Surgery at the Royal Infirmary in Edinburgh, Scotland, UK. He established a multidisciplinary program for Esophageal and Gastric cancers in NUH in 2005. He also received fellowship training in gastric and esophageal cancer surgery in Japan, Korea and Hong Kong. He is the pioneer in endoscopic surgery for early esophageal and gastric cancers, robotic surgery and Peroral Endoscopic Myotomy (POEM) for Achalasia in Singapore.


Prof. Jimmy So’s special interests are in gastroesophageal cancer and obesity. He has published more than 100 peer reviewed scientific papers and received many research grants for his research work on these topics. He received a Gold Award at the annual scientific meeting of the National Healthcare Group. He was invited regularly to speak at International Gastric Cancer Congress, Annual Scientific Meetings of Japanese Gastric Cancer Association and Korean International Gastric Cancer Week. He has also presented his works at American Gastroenterological Association (AGA), American Society of Gastrointestinal Endoscopy (ASGE), Society of American Gastrointestinal Endoscopic Surgeons (SAGES), and World Congress of Endoscopic Surgery.


He is founding president of the Asia-Pacific Gastro-esophageal Cancer Congress in 2006. In 2013, he was the council member of the Consensus Meeting at the 10th International Gastric Cancer Congress, held at Verona, Italy. He is also a founding member of Asia-Pacific Bariatric Surgery Society. Prof. So is a member of editorial board of Journal of Gastric Cancer and reviewer for a number of prestigious medical journals including British Journal of Surgery, Surgical Endoscopy and Digestive Disease and Science. Presently, he is actively involved in management of patients with gastric and esophageal cancers, morbid obesity and other Upper GI disorders. 

Dr. Wei-Peng YONG

Associate Director (Research) and Senior Consultant, 
Department of Haematology-Oncology, 
National University Cancer Institute, Singapore (NCIS), 
National University Hospital (NUH)

Dr. Wei-Peng Yong obtained his medical degree and postgraduate training in University of Aberdeen, Scotland. After completing an oncology fellowship at the National University Hospital, he was awarded the A*star international clinical pharmacology fellowship at the University of Chicago. Upon his return to Singapore, he was awarded a three-year Investigatorship Award under the Clinician Scientist Award to further his research into personalized therapy. Dr. Yong leads the therapeutic arm (NUH module) of the Singapore Gastric Cancer Consortium. The consortium received the prestigious five-year Translational Clinical Research grant in 2007. He is also the Chairman of the National Healthcare Group Domain-Specific Ethics Review Board. His clinical interest is in gastrointestinal cancers and his research interests are pharmacogenetics and epigenetics in cancer.


Professor Wee-Joo CHNG

Professor, Department of Medicine

Senior Consultant and Head, Department of Haematology-Oncology

National University Cancer Institute, National University Health System (NUHS)

National University Cancer Institute, NUHS

Deputy Director, 
Cancer Science Institute of Singapore, National University of Singapore

Vice-Dean, Research,
NUS Yong Loo Lin School of Medicine

Group Director, Research Office,
National University Health System (NUHS)


Prof. Wee-Joo Chng is the Director of the National University Cancer Institute of Singapore (NCIS) at the National University Health System, Singapore (NUHS). He is also the Group Director of Research Office at the National University Health System and Vice-Dean of Research at the Yong Loo Lin School of Medicine as well as the Deputy Director and a Senior Principal Investigator at the Cancer Science Institute (CSI), Singapore, National University of Singapore (NUS). Prof. Chng is also the Provost’s Chair Professor at the Yong Loo Lin School of Medicine, National University of Singapore.


He is a member of many international professional committees, such as American Society of Haematology Scientific Committee on Plasma Cell Neoplasia, the International Myeloma Working Group and the Asian Myeloma Network. He is also involved in a number of Grant Review Committees, Conference Organising Committee, Advisory Boards and Steering Committees of Global Clinical Trials. He has authored more than 200 publications in many reputed journals, and actively participates in clinical trials and has delivered talks in many national and international conferences. He has won multiple awards for his research both locally and internationally including the National Medical Excellence Outstanding Clinician Scientist Award, the National Medical Research Council Senior Translational Research (STaR) Award, The National University of Singapore Young Researcher Award, and the Celgene Future Leaders in Haematology Award.

A/Prof. Khay-Guan YEOH

Associate Professor, Department of Medicine

Senior Consultant, Division of Gastroenterology & Hepatology,
University Medicine Custer,
National University Health System (NUHS)

Deputy Chief Executive (Academic Enterprise),

National University Health System (NUHS)

Lead Principal Investigator,
Singapore Gastric Cancer Consortium


Dr. Khay-Guan Yeoh is Deputy Chief Executive, National University Health System, in which role he oversees clinical care planning and health system transformation. He practices as a Senior Consultant at the Division of Gastroenterology and Hepatology, NUH and served as Dean of the NUS School of Medicine from 2011 to 2018.


Dr. Yeoh‘s research interest is in enhancing the early detection of gastric and colorectal cancers. He is the Lead Principal Investigator of the Singapore Gastric Cancer Consortium, a national flagship research group, and chairs the National Colorectal Cancer Screening Committee of the Health Promotion Board, Ministry of Health. He has published over 170 peer-reviewed papers in international journals, 9 book chapters and has an H-index of 50. He was awarded the National Medical Excellence Award as Outstanding Clinician Scientist by the Ministry of Health, Singapore in 2013.